Doctors Note Logo

Published on: 1/4/2026

Is voltaren gel dangerous?

Generally safe when used as directed, Voltaren gel offers localized pain relief with lower systemic risks than oral NSAIDs, and most side effects are mild skin irritation. Serious issues are rare but can occur with large-area or prolonged use or in people with heart, kidney, liver, or stomach disease, during late pregnancy, or when combined with blood thinners or other NSAIDs; see below for dosing limits, interactions, and red flags that should prompt medical care.

answer background

Explanation

Is Voltaren Gel Dangerous?

Voltaren gel (diclofenac sodium topical gel) is a widely used, over-the-counter topical nonsteroidal anti-inflammatory drug (NSAID). It’s approved for relieving pain and reducing inflammation in joints just under the skin (e.g., knees, hands). Patients and caregivers often wonder about its safety: “Is Voltaren gel dangerous?” Below, we review the evidence, explain potential risks, and offer practical advice.


How Voltaren Gel Works

  • Voltaren gel contains diclofenac, an NSAID that blocks enzymes (COX-1 and COX-2) involved in making prostaglandins—chemicals that cause pain and swelling.
  • Applied directly to the painful area, it delivers medication locally, minimizing the amount absorbed into the bloodstream compared to oral NSAIDs.^1
  • Typical uses include osteoarthritis pain in knees, hands, or elbows.

Key Benefits

  • Localized pain relief without taking pills.
  • Lower risk of stomach, kidney, and heart side effects seen with oral NSAIDs.^1
  • Fast-acting: many patients feel improvement within days.
  • Over-the-counter availability in many countries (strengths vary).

Common Side Effects

Most side effects are mild and occur at the application site:

  • Skin irritation: redness, itching, burning, or dryness.
  • Rash or contact dermatitis.
  • Minor peeling or discoloration.

Tips to minimize skin reactions:

  • Apply only to clean, dry, intact skin.
  • Avoid bandaging or covering the area tightly after application.
  • Rotate application sites when possible.

Potential Systemic Risks

Although systemic absorption is low (<6% of an oral dose), some risk remains, especially with:

  • Large-area or long-term use.
  • Use under occlusive dressings.
  • Application on broken skin.

Possible systemic NSAID-related risks include:

  1. Gastrointestinal
    • Rare ulcers, bleeding, or perforation
    • Symptoms: abdominal pain, black stools, vomiting blood
  2. Cardiovascular
    • Slightly increased risk of heart attack or stroke with chronic, high-dose NSAIDs
  3. Renal (kidney)
    • Fluid retention, blood pressure rise, worsening kidney function
  4. Hepatic (liver)
    • Very rare liver enzyme elevations or injury

A 2015 Cochrane review of topical NSAIDs in acute and chronic pain found that serious adverse events were uncommon and similar to placebo.^1 However, caution is advised in patients with certain health conditions.


Special Precautions

Before using Voltaren gel, discuss your medical history with a healthcare provider, especially if you have:

  • Kidney disease or reduced kidney function
  • Heart disease, high blood pressure, or a history of stroke
  • Liver disease or elevated liver enzymes
  • A history of stomach ulcers or bleeding
  • Asthma triggered by NSAIDs
  • Pregnancy (avoid in third trimester) or breastfeeding

Patients with severe liver disease often use the Model for End-Stage Liver Disease (MELD) score to assess risk.^3 While topical diclofenac is unlikely to dramatically affect liver function, people with high MELD scores should proceed with extra caution.


Drug Interactions

Voltaren gel can interact with:

  • Oral NSAIDs (additive effects; avoid combining)
  • Anticoagulants (e.g., warfarin): increased bleeding risk
  • ACE inhibitors, diuretics: altered kidney function
  • Methotrexate, lithium: elevated blood levels

Always inform your doctor or pharmacist about all medications and supplements you take.


When to Stop and Seek Medical Help

Discontinue Voltaren gel and seek immediate medical attention if you experience:

  • Signs of severe skin reactions: blistering, extensive rash
  • Unexplained weight gain or swelling (hands, feet)
  • New or worsening stomach pain, black/tarry stools
  • Chest pain, shortness of breath, sudden weakness
  • Yellowing of skin or eyes, dark urine, severe fatigue

For less urgent concerns—such as persistent rash or mild gastrointestinal discomfort—talk to your doctor or pharmacist.


Practical Tips for Safe Use

  • Follow the package directions: do not exceed recommended daily dose (typically 2–4 grams per joint area, up to four times daily).
  • Wash hands before and after applying (unless you’re treating your hands).
  • Do not apply heat (e.g., heating pad) on top of treated skin.
  • Avoid covering the area with tight bandages or dressings.
  • Store at room temperature, away from children’s reach.

Summary: Balancing Benefits and Risks

  • Efficacy: Voltaren gel effectively relieves joint pain with a lower systemic side-effect profile than oral NSAIDs.^1
  • Safety: Generally safe when used correctly. Local skin reactions are the most common complaint.
  • Serious Risks: Rare but possible—gastrointestinal bleeding, cardiovascular or renal effects, liver injury—mainly with misuse or preexisting conditions.

You may also consider doing a free, online “symptom check for ” by clicking symptom check for to get personalized guidance on your pain.


Final Advice

  • Always read and follow the label instructions.
  • Discuss with your healthcare provider before starting Voltaren gel, especially if you have heart, kidney, liver, or gastrointestinal issues.
  • If you suspect a serious reaction or life-threatening problem, seek medical help immediately—don’t wait.

Remember, this information is meant to guide you but does not replace professional medical advice. Speak to a doctor about any concerns or symptoms that could be serious.

References:

  1. Derry S, Moore RA, McQuay HJ. Topical NSAIDs for acute and chronic pain in adults. Cochrane Database Syst Rev, CD007402. 26504893.
  2. Ziol M, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness. Hepatology. 15649719.
  3. Kamath PS, Kim WR. The Model for End-Stage Liver Disease (MELD). Semin Liver Dis. 17909928.
Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.